Mizuho Starts Select Medical Holdings (SEM) at Outperform

Mizuho analyst Ann Hynes initiates coverage on Select Medical Holdings (NYSE: SEM) with a Outperform rating and a price target of $25.00.

The analyst commented: "We believe SEM is an attractive long-term investment opportunity given the company’s leading position in the post-acute continuum of care, attractive growth profile, improved leverage profile and attractive valuation. We believe earnings visibility is solid for SEM given the company’s continued diversification and acceleration into fast-growing inpatient rehabilitation, coupled with margin expansion potential in outpatient rehabilitation. We believe upside comes from faster-than-expected growth in inpatient rehabilitation, and free cash deployment in the form of share repurchases or yet unannounced M&A."

For an analyst ratings summary and ratings history on Select Medical Holdings click here. For more ratings news on Select Medical Holdings click here.

Shares of Select Medical Holdings closed at $16.30 yesterday.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
• Crusoe in talks to raise $3B in funding - Bloomberg